Inhalation drug product testing
New IRCA Approved Course
IRCA GMP lead auditor (pharmaceutical quality systems) – PR325
Diversity & Inclusion
Hosted by RSSL's Daniel Nicolau, this webinar considers the challenges of method development for nitrosamine analysis and the risk nitrosamines can pose.NITROSAMINES ANALYSIS - BETTER UNDERSTANDING THE RISKAnalysing a pharma product for all possible nitrosamines can involve a long process of method development and validation, particularly in complex matrices with low analytical thresholds. But are there better methods available?By targeting the most likely occurring nitrosamines for a product by utilising unique chemistry and formulation, may better describe the risk and reduce the complexity and time of laboratory analysis.In this webinar we discuss:
To view this webinar on demand please click here.